Company / Total Debt
RECURSION PHARMACEUTICALS, INC. Total Debt History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$723.0K
FY2021
5-year range
$723.0K / $723.0K
FY2021-FY2021
Trend
-
vs FY2020
Sector context
#80 of 83
Health Care
What the data says
Among 83 Health Care companies, RECURSION PHARMACEUTICALS, INC. is in the top 4% for total debt.
Based on SEC 10-K filings.
$723,000 in FY2021.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 83This company $723.0K Sector average $6.2B
▼
-100.0% below sector average
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $723.0K | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026